Quest Diagnostics - Press Releases

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996

Quest Diagnostics Reports Third Quarter 2021 Financial Results, Raises Outlook for Full Year 2021

10/21/21

Quest Diagnostics to Provide K-12 School COVID-19 Testing in Collaboration with Ginkgo Bioworks to Support Safer Classroom Learning in Texas for New Statewide School Testing Program

10/20/21

Quest Diagnostics to Introduce Ki-67 IHC MIB-1 pharmDx, the First Companion Diagnostic for Eli Lilly and Company's Verzenio® (abemaciclib), a CDK4/6 Inhibitor for Certain People with HR+ HER2- High Risk Early Breast Cancer

10/18/21

Quest Diagnostics Debuts Next-Generation Lab Facility in Clifton, NJ

10/12/21

Quest Diagnostics and the Boston Athletic Association Team Up to Provide Onsite COVID-19 Diagnostic Testing for the 125th Boston Marathon

10/05/21

Quest Diagnostics To Release Third Quarter 2021 Financial Results On October 21

09/29/21

Over Half of U.S. Children Have Detectable Levels of Lead in their Blood, Finds Quest Diagnostics Health Trends® Study Published in JAMA Pediatrics

09/28/21

Quest Diagnostics Updates Outlook For Full Year 2021

09/09/21

Cancer Diagnoses Declined Sharply During First Year of COVID-19 Pandemic, Finds Quest Diagnostics Health Trends® Study Published in JAMA Network Open

08/31/21

Quest Diagnostics to Speak at the Morgan Stanley 19th Annual Global Healthcare Conference

08/30/21

Quest Diagnostics Elects Tracey C. Doi to Board of Directors

08/17/21

Quest Diagnostics Declares Quarterly Cash Dividend

08/16/21

Quest Diagnostics Reports Second Quarter 2021 Financial Results; Establishes Full Year 2021 Outlook

07/22/21

Quest Diagnostics Named a "Best Place to Work for Disability Inclusion" for Fourth Consecutive Year

07/14/21

Quest Diagnostics and Local Chapters of Feeding America, Big Brothers Big Sisters and Federally Qualified Health Centers Team Up to Address the Hidden Pandemic's Impact on Underserved Communities

07/12/21

Quest Diagnostics To Release Second Quarter 2021 Financial Results On July 22

07/06/21

Quest Diagnostics Releases Annual Corporate Responsibility Report

06/21/21

Quest Diagnostics Completes Acquisition of Mercy's Outreach Laboratory Services Business

06/01/21

Marijuana Workforce Drug Test Positivity Continues Double-Digit Increases to Keep Overall Drug Positivity Rates at Historically High Levels, Finds Latest Quest Diagnostics Drug Testing Index™ Analysis

05/26/21

Quest Diagnostics and Paige Form Collaboration to Advance AI-generated Pathology Insights to Improve Cancer Diagnosis and Care

05/25/21

Social & Health Research Center and Quest Diagnostics Team Up to Address Childhood Hunger and Obesity Exacerbated by COVID-19 in Underserved Communities

05/24/21

Quest Diagnostics Declares Quarterly Cash Dividend

05/20/21

Quest Diagnostics To Speak At The Jefferies Virtual Healthcare Conference

05/19/21

Quest Diagnostics Expands Eligibility for $0 Out-of-Pocket COVID-19 Testing Through QuestDirect™ To Assist in Combatting the Pandemic and Help Support Safer Travel, Events and Gatherings Nationwide

05/11/21

New Health Trends® Study by Quest Diagnostics in Collaboration with CDC Reveals Concerning Decreases in Hepatitis C Testing and Treatment During First Months of COVID-19 Pandemic

05/11/21

Quest Diagnostics To Speak At BofA Securities 2021 Virtual Healthcare Conference

04/27/21

Quest Diagnostics Reports First Quarter 2021 Financial Results; Announces Plan for $1.5 Billion Accelerated Share Repurchase

04/22/21

Quest Diagnostics and Blueprint Genetics to Present New Insights from Genetic Testing at the 2021 Annual American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting

04/13/21

Quest Diagnostics To Release First Quarter 2021 Financial Results On April 22

04/07/21

Quest Diagnostics Sells Ownership Interest in Q² Solutions to IQVIA

04/01/21

Zora Biosciences Licenses Ceramide Technology to Quest Diagnostics for Cardiovascular Mortality Prediction Test

03/15/21

Quest Diagnostics Updates Strategic Growth Drivers and Provides Long-Term Outlook at 2021 Virtual Investor Day

03/11/21

Quest Diagnostics and Mercy Broaden Access to Innovative, Convenient Lab Services in the Midwest

03/08/21

Quest Diagnostics Introduces New COVID-19 Semi-quantitative Serology Test Service

02/24/21

Quest Diagnostics Announces Board Leadership Changes

02/23/21

Quest Diagnostics To Speak At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference

02/16/21

EmblemHealth and Quest Diagnostics Renew Long-Standing Strategic Relationship

02/16/21

Quest Diagnostics to Host Virtual Investor Day On March 11, 2021

02/09/21

Quest Diagnostics Reports Fourth Quarter And Full Year 2020 Financial Results; Establishes Outlook For First Half Of 2021

02/04/21

Quest Diagnostics Increases Dividend 10.7% To $0.62 Per Quarter; Announces $1 Billion Increase in Share Repurchase Authorization

02/04/21

Quest Diagnostics Named One of 2021 "World's Most Admired Companies" by FORTUNE Magazine for Seventh Consecutive Year

02/01/21

With COVID-19 on the Rise Amid Vaccine Shortages, Black Clergy Join National Effort to Ramp up COVID-19 Testing in Communities Hardest Hit by Coronavirus

01/26/21

Black and Hispanic/Latinx Americans Less Confident in Ability to Access COVID-19 Vaccines, Treatments and Healthcare than White Americans, Finds Quest Diagnostics Health Trends™ Analysis

01/18/21

Quest Diagnostics Granted CDC Contract to Sequence COVID-19 Gene Variants to Aid Public Health Response to COVID-19

01/18/21

Quest Diagnostics To Release Fourth Quarter And Full Year 2020 Financial Results On February 4

01/13/21